[PCRX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
20-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 19.70%
YoY- -159.00%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 171,955 159,194 128,548 122,424 95,115 79,078 72,902 15.36%
PBT -18,068 -6,197 12,693 -3,541 8,322 4,630 -3,994 28.58%
Tax -7,966 -1,068 -1,821 1,347 37 35 -21 168.93%
NP -10,102 -5,129 14,514 -4,888 8,285 4,595 -3,973 16.82%
Tax Rate - - 14.35% - -0.44% -0.76% - -
Total Cost 182,057 164,323 114,034 127,312 86,830 74,483 76,875 15.44%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -5.87 -3.22 11.29 -3.99 8.71 5.81 -5.45 1.24%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.22 -0.12 0.33 -0.12 0.20 0.11 -0.11 12.24%
EPS Diluted -0.22 -0.12 0.32 -0.12 0.20 0.11 -0.11 12.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.